1-7 of 7
Fabrizio Ciambelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pomalidomide, Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Lenalidomide and Anti-CD38 Monoclonal Antibodies: A Multicentric Italian Retrospective Study

Carmine Liberatore, Paola Tacchetti, Concetta Conticello, Gregorio Barila, Elisabetta Antonioli, Angelo Belotti, Anna Maria Cafro, Laura Paris, Velia Bongarzoni, Massimo Gentile, Matteo DA VIA, Barbara Gamberi, Sara Pezzatti, Fabrizio Ciambelli, Mariagrazia Garzia, Ombretta Annibali, Francesca Fazio, Giusy Antolino, Nicola Sgherza, Francesca Farina, Annalisa Citro, Monica Galli, Vittorio Del Fabro, Claudio Salvatore Cartia, Francesca Fioritoni, Katia Mancuso, Irene Attucci, Maria Luisa Pioltelli, Michele Puppi, Sofia Terlizzi, Chiara Lisi, Virginia Valeria Ferretti, Massimo Offidani, Maria Teresa Petrucci, Silvia Mangiacavalli
Journal: Blood
Blood (2024) 144 (Supplement 1): 5153.
https://doi.org/10.1182/blood-2024-204021
Published: 2024
Journal Articles

Rituximab and Lenalidomide (R 2 ) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL)

Carola Boccomini, Barbara Botto, Andrea Evangelista, Vittorio Ruggero Zilioli, Antonella Anastasia, Federica Cavallo, Francesco Merli, Manuela Zanni, Monica Tani, Annalisa Chiarenza, Anna Marina Liberati, Annarita Conconi, Paolo Corradini, Alessia Bari, Giorgia Annechini, Gianluca Gaidano, Michele Spina, Roberto Sartori, Claudia Castellino, Benedetta Puccini, Annalisa Arcari, Sara Bigliardi, Giorgia Matta, Michele Merli, Donato Mannina, Dario Marino, Piero Galieni, Fabrizio Ciambelli, Gerardo Musuraca, Chiara Bottelli, Cristina Muzi, Simone Ferrero, Stefano Luminari, Marco Ladetto, Giovannino Ciccone, Umberto Vitolo
Journal: Blood
Blood (2023) 142 (Supplement 1): 982.
https://doi.org/10.1182/blood-2023-174901
Published: 2023
Journal Articles

Impact of Bortezomib- or Lenalidomide-Based Induction Treatment on High Risk Cytogenetic Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Enrolled in the Gimema-MM-03-05 and EMN01 Trials

Alessandra Larocca, Massimo Offidani, MD, Pellegrino Musto, MD, Francesca Patriarca, MD, Lorenzo De Paoli, MD, Paolo Corradini, MD, Marco Salvini, MD, Clotilde Cangialosi, MD, Tommasina Guglielmelli, MD, Giovannino Ciccone, Fausto Dore, MD, Angelo Belotti, MD, Mattia D'Agostino, MD, Felicetto Ferrara, MD, Daniela Oddolo, Riccardo Centurioni, MD, Fabrizio Ciambelli, MD, Stefano Spada, Donatella Iolanda Vincelli, MD, Michele Cavo, MD, Nicola Giuliani, MD PhD, Alberto Bosi, MD, Concetta Conticello, MD, Roberto Ria, MD, Maria Teresa Petrucci, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 744.
https://doi.org/10.1182/blood.V130.Suppl_1.744.744
Published: 2017
Journal Articles

Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

Paola Tacchetti, MD, Lucia Pantani, MD, Valerio De Stefano, MD, Elena Zamagni, MD, Jacopo Peccatori, MD, Annalisa Pezzi, Statistician, Catello Califano, MD, Andrea Nozza, MD, Patrizia Tosi, MD, Carolina Terragna, PhD, Fabrizio Ciambelli, MD, Delia Cangini, MD, Piero Galieni, MD, Clotilde Cangialosi, MD, Giovanni De Sabbata, MD, Francesca Elice, MD, Antonio Palumbo, MD, Michele Cavo, MD
Journal: Blood
Blood (2014) 124 (21): 196.
https://doi.org/10.1182/blood.V124.21.196.196
Published: 2014
Journal Articles

Bortezomib, Melphalan, Prednisone and Thalidomide Followed by Maintenance with Bortezomib and Thalidomide (VMPT-VT) for Initial Treatment of Elderly Multiple Myeloma Patients: Updated Follow-up and Impact of Prognostic Factors

Antonio Palumbo, Sara Bringhen, Maide Cavalli, Roberto Ria, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Renato Zambello, Giuseppe Pietrantuono, Luca De Rosa, Anna Marina Liberati, Claudia Crippa, Giulia Perrone, Fabrizio Ciambelli, Angelo Michele Carella, Salvatore Palmieri, Milena Gilestro, Valeria Magarotto, Maria Teresa Petrucci, Pellegrino Musto, Gianluca Gaidano, Mario Boccadoro
Journal: Blood
Blood (2010) 116 (21): 620.
https://doi.org/10.1182/blood.V116.21.620.620
Published: 2010
Journal Articles

A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens.

Antonio Palumbo, MD, Michele Cavo, Sara Bringhen, Maide Cavalli, Francesca Patriarca, Davide Rossi, Paola Tacchetti, Norbert Pescosta, Claudia Crippa, Monica Galli, Tonino Spadano, Angelo Michele Carella, Tommaso Caravita, Claudia Cellini, Antonio Ledda, Francesco Pisani, Jacopo Peccatori, Francesca Elice, Andrea Nozza, Valerio De Stefano, Luca De Rosa, Anna Marina Liberati, Fabrizio Ciambelli, Giovanni De Sabbata, Lucio Catalano, Alessandra Larocca, Fortunato Morabito, Elena Zamagni, Massimo Offidani, Patrizia Tosi, Mario Boccadoro
Journal: Blood
Blood (2009) 114 (22): 492.
https://doi.org/10.1182/blood.V114.22.492.492
Published: 2009
Journal Articles

A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens

Michele Cavo, MD, Antonio Palumbo, M.D., Sara Bringhen, M.D., Antonietta Falcone, M.D., Pellegrino Musto, M.D., Fabio Ciceri, M.D., Mariella Grasso, M.D., Renato Zambello, M.D., Maria Concetta Petti, M.D., Fabrizio Ciambelli, M.D., Giovanni De Sabbata, M.D., Stefano Rocco, M.D., Luigi Gugliotta, M.D., Filippo Gherlinzoni, M.D., Alfonso D’Arco, M.D., Massimo Martelli, M.D., Tommasina Guglielmelli, M.D., Paola Tacchetti, M.D., Michele Baccarani, M.D., Mario Boccadoro
Journal: Blood
Blood (2008) 112 (11): 3017.
https://doi.org/10.1182/blood.V112.11.3017.3017
Published: 2008